Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2013

Jun 6, 2013

29777_rns_2013-06-06_7a05cb61-9bf8-4782-8b6e-4c7477bc5e89.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

SEC FORM 4 Page 1 of 1

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

☐ Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden hours per response: 0.5
1. Name and Address of Reporting Person* LINDER GREG W
Director 10% Owner
X Officer (give title below)
Other (specify below)
Vice President
--- --- ---
(Last) (First) (Middle)
100 ABBOTT PARK ROAD
02/08/2011
(Street)
ABBOTT PARK IL 60064-6400
(City) (State) (Zip)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year)
Common shares without par value 02/08/2011
Common shares without par value 02/08/2011
Common shares without par value 02/08/2011
Common shares without par value
Profit Sharing Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
--- --- ---
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)
Option (right to buy) (2) $45.4488 02/08/2011

Explanation of Responses:

  1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 8, 2011.
  2. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

John A. Berry, by power of attorney for Greg W. Linder 02/10/2011

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911011002411/xslF345X03/ed... 09/05/2013